IPT-G for Mums With Postpartum Depression
OPTIMUM
Out-patient Group Therapy Using Interpersonal Psychotherapy for Mums With Postpartum Depression: the OPTIMUM Study: a Randomized Controlled Trial
1 other identifier
interventional
95
1 country
1
Brief Summary
Postpartum depression is a very common and costly illness with numerous, long-term deleterious effects for women, their offspring and families; yet most women are not treated. Group IPT delivered virtually offers women a 1st-line, low-cost intervention that overcomes existing treatment barriers. To test its acceptability and effectiveness, a RCT will be conducted to compare virtually delivered group IPT immediately to usual care in women in Ontario Canada who have postpartum depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 25, 2020
CompletedFirst Posted
Study publicly available on registry
October 9, 2020
CompletedStudy Start
First participant enrolled
December 21, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedNovember 6, 2024
November 1, 2024
1.2 years
September 25, 2020
November 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Depressive symptoms on Edinburgh Postpartum Depression scale
Pre-treatment to post-treatment comparison of depressive symptoms measured via EPDS. Scale is measured from 1 (no depressive symptoms) to 4 (worst depressive symptoms) with 0 being the lowest score (best outcome) and 30 being the highest score (worst outcome).
To be measured immediately after 12 weeks of group IPT
Depressive symptoms on Patient Health Questionnaire-9 (PHQ-9)
Pre-treatment to post-treatment comparison of depressive symptoms measured via PHQ-9. Scale is measured from 0 (no depressive symptoms) to 3 (worst depressive symptoms) with 0 being the lowest score (best outcome) and 27 being the highest score (worst outcome).
To be measured immediately after 12 weeks of group IPT
Secondary Outcomes (6)
Anxiety
Immediately after 12 weeks of group IPT
Acceptability
Immediately after 12 weeks of group IPT
Social Support
Immediately after 12 weeks of group IPT
Functioning
Immediately after 12 weeks of group IPT
Anxiety
Immediately after 12 weeks of group IPT
- +1 more secondary outcomes
Study Arms (2)
Group interpersonal psychotherapy
EXPERIMENTALGroup IPT consists of 12 weeks of virtually delivered therapy by two co-therapists via Zoom to a group of 6-8 women. The 12 weeks consist of 15 sessions over 12 weeks of group IPT taking place virtually via Zoom (2 sessions per week for the first 4 weeks (acute phase) then once a week for 6 weeks, then a two-week space before the last session).
Usual care
NO INTERVENTIONUsual care refers to any care that the women wish to access, and there are no limits on the women in either group. It may include, but is not limited to, the family physician, obstetrician, and/or midwife, participation in regional standard perinatal depression programming, private therapy, online therapies, medication, etc.
Interventions
Group IPT consists of 12 weeks of virtually delivered therapy by two co-therapists via Zoom to a group of 6-8 women. The 12 weeks consist of 15 sessions over 12 weeks of group IPT taking place virtually via Zoom (2 sessions per week for the first 4 weeks (acute phase) then once a week for 6 weeks, then a two-week space before the last session).
Eligibility Criteria
You may qualify if:
- age 18 years or older
- postpartum with baby under 1 year
- score greater than or equal to 10 on the Edinburgh Postnatal Depression Scale (EPDS)
You may not qualify if:
- active alcohol or substance use disorder
- bipolar disorder
- borderline personality
- antisocial personality
- PTSD
- psychosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
McMaster Univeristy
Hamilton, Ontario, L8S 4L8, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vivian Polak, HBA BMSc MD
McMaster University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 25, 2020
First Posted
October 9, 2020
Study Start
December 21, 2020
Primary Completion
March 1, 2022
Study Completion
March 1, 2022
Last Updated
November 6, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share